MarkaRaeCrittendenMD

Radiation Oncology • Portland, OR

Physician

Join to view full profile

Dr. Crittenden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Crittenden's full profile

Already have an account?

Office
4805 Ne Glisan St
Garden Level
Portland, OR 97213
Phone+1 503-215-6029

Fax+1 503-215-6387

Education & Training

Oregon Health & Science University (OHSU Health)Residency, Radiation Oncology, 2005 - 2009
Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterInternship, Internal Medicine, 2004 - 2005
Mayo Clinic College of MedicineClass of 2004

Certifications & Licensure

OR State Medical License 2009 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Start of enrollment: 2010 Oct 14
Completed
Phase 1
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions Start of enrollment: 2012 Apr 27
Completed
Phase 1
Chemoimmunotherapy and Radiation in Pancreatic Cancer Start of enrollment: 2013 Jul 01
Completed
Phase 1
Phase I Study of Safety and Immunogenicity of ADU-623 Start of enrollment: 2014 Jan 08
Completed
Phase 1
Immunoscore in Rectal Cancer Start of enrollment: 2014 Jan 24
Completed
Join now to see all

Publications & Presentations

PubMed

A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression.
Jason R Baird, Alejandro F Alice, Roland Saito, Qingqing Chai, Minhua Han
Scientific Reports. 2024-12-02
1 citations
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.
Justin C Jagodinsky, Jessica M Vera, Won Jong Jin, Amanda G Shea, Paul A Clark
Science Translational Medicine. 2024-09-18
2 citations
Fluorescence tracking demonstrates T cell recirculation is transiently impaired by radiation therapy to the tumor.
Gwen Kramer, Tiffany Blair, Shelly Bambina, Aanchal Preet Kaur, Alejandro Alice
Scientific Reports. 2024-05-24

Lectures

Combining Immunotherapy With Radiation
2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

Chair for Cancer Research AnnouncedMay 2nd, 2021